Rani Therapeutics Inc.

NASDAQ: RANI · Real-Time Price · USD
0.55
-0.01 (-1.22%)
At close: Aug 15, 2025, 3:58 PM

Rani Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
10.22M 10.11M 3.76M 4.28M 4.51M 7.38M 6.36M 4.97M 7.55M 18.98M 27.01M 27.22M 97.18M 107.84M 117.45M 129.74M 69.31M 76.66M
Short-Term Investments
n/a 5.74M 23.88M 26.13M 26.39M 32.7M 42.67M 55.55M 67.05M 67.8M 71.47M 70.95M n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 500K n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
293K 246K 246K 246K 246K 246K 546K n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.41M 785K
Receivables
18K 600K 428K 200K 100K 200K 200K 200K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a -200K -200K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
839K 1.33M 1.68M 1.77M 1.03M 466K 500K 2.7M 1.77M 2.25M 2.44M n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
11.07M 17.78M 29.74M 32.37M 32.03M 41.39M 50.85M 63.22M 76.37M 89.04M 100.92M 100.72M 97.99M 109.26M 119.59M 132.37M 69.48M 76.8M
Property-Plant & Equipment
5.53M 6.1M 6.64M 10.92M 11.45M 11.88M 6.82M 7.21M 7.13M 7.41M 7.1M 6.98M 6.35M 6.05M 4.61M 4.59M 4.43M 4.49M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
5.83M 6.34M 6.89M 11.17M 11.69M 12.12M 7.37M 7.21M 7.13M 7.41M 7.1M 7.48M 6.35M 6.05M 4.61M 4.59M 7.84M 5.28M
Total Assets
16.9M 24.13M 36.63M 43.54M 43.73M 53.51M 57.92M 70.44M 83.51M 96.45M 108.03M 108.2M 104.34M 115.31M 124.21M 136.96M 77.32M 82.08M
Account Payables
1.8M 1.52M 1.36M 1.57M 506K 806K 648K 1.41M 1.04M 1.51M 1.46M 1.79M 1.44M 1.26M 1.08M 1.31M 1.67M 943K
Deferred Revenue
334K n/a 1.44M 600K n/a n/a n/a n/a 3.31M n/a n/a n/a n/a n/a n/a n/a 3.45M 1.96M
Short-Term Debt
16.19M 15M 15M 14.77M 12.29M 8.59M 4.9M 1.22M 856K n/a 1.01M 984K 658K 650K n/a n/a 3.88M 1.95M
Other Current Liabilities
1.93M 310K 283K 1.54M 2.15M 1.62M 1.41M 1.95M 595K 360K 995K 423K 556K 341K 126K 860K 1.88M 853K
Total Current Liabilities
20.62M 20.13M 19.89M 20.21M 16.58M 13.38M 7.99M 7.34M 5.74M 5.15M 4.82M 7.19M 5.35M 4.16M 2.64M 5.25M 9.36M 7.09M
Long-Term Debt
3.2M 5.92M 9.61M 13.54M 17.21M 20.85M 24.48M 28.1M 29.27M 29.21M 29.15M 14.09M n/a n/a n/a n/a n/a 1.89M
Other Long-Term Liabilities
2.23M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 191.64M 191.57M
Total Long-Term Liabilities
5.43M 9.34M 13.25M 17.55M 21.59M 25.6M 24.48M 28.27M 29.6M 29.71M 29.21M 14.41M 341K 509K 1.08M n/a 191.64M 193.46M
Total Liabilities
26.05M 29.47M 33.14M 37.77M 38.18M 38.98M 32.47M 35.62M 35.34M 34.86M 34.02M 21.59M 5.69M 4.67M 2.64M 5.25M 201M 200.55M
Total Debt
19.39M 25.67M 29.71M 33.73M 35.25M 35.41M 30.1M 30.28M 30.46M 30.63M 30.21M 15.39M 999K 1.16M n/a n/a 3.88M 3.84M
Common Stock
5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 5K 1.41M 1.13M
Retained Earnings
-116.86M -110.17M -102.91M -93.96M -87.18M -80.37M -72.89M -65.79M -56.59M -47.29M -38.92M -30.13M -22.18M -14.55M -8.33M -3.14M -125.09M -119.6M
Comprehensive Income
3K 2K 5K 8K -5K -11K -12K -41K -63K -10K -73K -57K -0.00 -0.00 -0.00 -136.96M -0.00 -192.7M
Shareholders Equity
-5.58M -3.06M 1.99M 3.12M 2.83M 7.4M 12.87M 17.55M 24.09M 30.72M 36.85M 42.19M 47.81M 53.38M 47.41M 51.37M -123.67M -118.47M
Total Investments
n/a 5.74M 23.88M 26.13M 26.39M 32.7M 42.67M 55.55M 67.05M 67.8M 71.47M 70.95M n/a n/a n/a n/a n/a n/a